SCHEMBL9288147

SCHEMBL9288147

COC(=O)COc1ccc(C(C)(C)C)cc1C[SiH](C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.47
PPARG P37231 2/20 0.46
PPARD Q03181 2/20 0.46
PPARA Q07869 2/20 0.46
KMT2A Q03164 6/20 0.43
MEN1 O00255 5/20 0.43
HTT P42858 2/20 0.43
LMNA P02545 1/20 0.42
ALDH1A1 P00352 6/20 0.40
NPSR1 Q6W5P4 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 4/20 0.40
KDM4E B2RXH2 1/20 0.40
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9124508 0.86 CYP2C19 (0.44) CYP2C19PPARGPPARDPPARAKMT2A
SCHEMBL13757708 0.83 CYP2C19 (0.54) CYP2C19PPARGPPARDPPARAKMT2A
SCHEMBL20669301 0.80 PTGDR2 (0.51) CYP2C19KMT2AMEN1HTTLMNA
SCHEMBL7846867 0.80 CYP2C19 (0.51) CYP2C19KMT2AMEN1HTTLMNA
SCHEMBL7844241 0.80 CYP2C19 (0.51) CYP2C19KMT2AMEN1HTTLMNA
SCHEMBL13321439 0.79 CYP2C19 (0.50) CYP2C19PPARGPPARDPPARAKMT2A
SCHEMBL13757721 0.78 CYP2C19 (0.49) CYP2C19PPARGPPARDPPARAKMT2A
SCHEMBL1276562 0.76 MAPT (0.52) CYP2C19PPARGPPARDPPARAKMT2A
SCHEMBL11270474 0.75 SMN1; SMN2 (0.46) CYP2C19PPARGPPARDPPARAKMT2A
SCHEMBL4909292 0.73 CYP2C19 (0.68) CYP2C19PPARGPPARDPPARAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0517812-A4 ANGIOTENSIN II ANTAGONISTS INCORPORATING A SUBSTITUTED BENZYL ELEMENT MERCK & CO INC (US) 1995-10-18 EP disclosed
EP-0517812-A1 ANGIOTENSIN II ANTAGONISTS INCORPORATING A SUBSTITUTED BENZYL ELEMENT MERCK & CO. INC. (US) 1992-12-16 EP disclosed